Method for treating cardiac inotropic irregularities

Details Method for treating cardiac inotropic irregularities Method for treating cardiac inotropic irregularities

1994-07-28

1996-01-23

Robinson, Douglas W.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

514557, 514821, 536 5, 554224, A61K 3119, A61K 31705, A01N 3700

Patent

active

054865069

ABSTRACT:
The invention describes a method for normalizing a cardiac inotropic irregularity, via administering an effective amount of 12(R)HETE. Also described are therapeutic compositions which combine a cardiac glycoside and 12(R)HETE.

REFERENCES:
patent: 4906467 (1990-03-01), Schwartzman et al.
patent: 5102670 (1992-04-01), Abraham
Otsuji et al. Igaku no Ayumi, 151(9), pp. 563-564, (1989) [Abstract only].
Kuzuya et al. Cardiovascular Res., 21(8), pp. 551-558, (1987) [Abstract only].
McCluskey et al. Prostaglandins, 29(3), pp. 387-403, (Mar. 1985) [Abstract only].
Masferrer et al., Invest. Opthalmol. Visual Sci. 31(3):535-536 (Mar. 1990).
Masferrer, Biochem. Pharmacology, 39(12):1971-1974 (1990).
Geroski et al., Invest. Opthalmol. Visual Sci., 31 (No. 716[(p. 145(1990).
Edelhauser, Invest. Opthalmol. Visual Sci. 32(4) No. 2491, p. 1177 (1991).
The Merck Index, 10th Ed.; Windholz et al, Eds. (1983) pp. 458-459, 676, 990.
Goodman & Gilman's , The Pharmacological Basis of Therapeutics 7th Ed. (1985) pp. 718-738.

Affiliated with

Also associated with

Rating

Method for treating cardiac inotropic irregularities does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for treating cardiac inotropic irregularities, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating cardiac inotropic irregularities will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1505063